搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
7 天
Trastuzumab deruxtecan是一种抗人表皮生长因子受体 2抗体-活性分子偶联物 ...
产品活性: Trastuzumab deruxtecan (T-DXd; DS-8201a) 是一种抗人表皮生长因子受体 2 (HER2) 抗体-活性分子偶联物 (ADC)。Trastuzumab deruxtecan 由人源化抗 HER2 ...
Chip Chick on MSN
18 小时
This Doctor Was Diagnosed With The Same Cancer He Spent His Life Studying
Among Asian Americans, lung cancer rates have been rising in the past several decades with no smoking history. Dr. Bryant […] ...
Benzinga.com
19 小时
FDA Approves AstraZeneca's Blockbuster Cancer Drug Imfinzi For Aggressive Form Of Lung Cancer
In August, the FDA approved Imfinzi (durvalumab) in combination with chemotherapy for adult patients with resectable ...
GlobalData on MSN
1 天
Reveal Genomics and IEO initiate breast cancer test impact study
Reveal Genomics and the Istituto Europeo di Oncologia (IEO) have initiated an impact study of the genomic test, HER2DX, to ...
EurekAlert!
3 天
How combining drugs may be more effective at treating HER2-positive breast cancer
Elena Shagisultanova, MD, PhD, is working to uncover effective treatments for HER2-positive breast cancer patients by combining different drugs to counteract the cancer cells’ proliferation.
2 天
MRK: Sac-TMT Gets FDA Breakthrough Therapy Designation For EGFR-mutated Advanced Or ...
Merck & Co., Inc. (MRK) announced Tuesday that the U.S. Food and Drug Administration has granted Breakthrough Therapy designation to ...
The Brighterside of News on MSN
5 天
Cutting-edge discovery looks to transform type 1 diabetes, cancer and autoimmune disease care
Regenerative medicine has the potential to reshape how we treat diseases, offering new hope for patients requiring cell, ...
2 天
Merck: FDA grants Breakthrough Therapy designation to sacituzumab tirumotecan
Merck (MRK) announced that the U.S. FDA has granted Breakthrough Therapy designation to sacituzumab tirumotecan for the treatment of patients ...
News Medical
3 天
How Dysregulated Cell Signaling Causes Disease
Dysregulated cell signaling underlies various diseases, emphasizing the importance of understanding these pathways for ...
2 天
Novartis In-Licenses PTCT's Huntington's Disease Drug for $2.9 Billion
Novartis will make an upfront payment of $1.0 billion to PTCT and the latter will also be eligible for up to $1.9 billion in ...
Baystate Health
9 天
Triple-Negative Breast Cancer: From Diagnosis to Treatment
Both rare and aggressive, triple-negative breast cancer accounts for 10-15% of all breast cancers. Dr. Bhardwaj says, “TNBC ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈